These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14597465)

  • 1. Patent cardiac foramen ovale: stroke risk and closure.
    Mohr JP; Homma S
    Ann Intern Med; 2003 Nov; 139(9):787-8. PubMed ID: 14597465
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.
    Khairy P; O'Donnell CP; Landzberg MJ
    Ann Intern Med; 2003 Nov; 139(9):753-60. PubMed ID: 14597460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with stroke and a patent foramen ovale.
    Rodriguez CJ; Homma S
    Curr Cardiol Rep; 2004 Mar; 6(2):143-6. PubMed ID: 14759360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.
    Felberg RA
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):4-5. PubMed ID: 17173277
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent foramen ovale and cryptogenic stroke. A critical review.
    Ballerini L; Cifarelli A; Ammirati A; Gimigliano F
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):34-8. PubMed ID: 17255814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On horse sense and horse feathers: an argument against insistence on enrolling cryptogenic stroke patients with patent foramen ovale in randomized clinical trials.
    Kramer P
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):1-3. PubMed ID: 17173276
    [No Abstract]   [Full Text] [Related]  

  • 7. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent foramen ovale: paradoxical embolism and paradoxical data.
    Adams HP
    Mayo Clin Proc; 2004 Jan; 79(1):15-20. PubMed ID: 14708944
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials.
    Kaplan AV; Lukovits TG; Robb JF
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):6-8. PubMed ID: 17173274
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac function after percutaneous closure of patent foramen ovale.
    Rao PS; Lorch S
    J Invasive Cardiol; 2007 Jun; 19(6):255-6. PubMed ID: 17541125
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous patent foramen ovale (PFO) closure: It can be done but should it?
    Windecker S; Meier B
    Catheter Cardiovasc Interv; 1999 Jul; 47(3):377-80. PubMed ID: 10402301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Was it paradoxal embolism? Cerebellar infarction, patent foramen ovale and APC resistance--a controversial combination and and therapeutic challenge].
    Valladares C; Broqvist M; Nylander E; Callander M
    Lakartidningen; 2006 Mar 15-21; 103(11):845-6, 848. PubMed ID: 16613113
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent foramen ovale and recurrent stroke: another paradoxical twist.
    Halperin JL; Fuster V
    Circulation; 2002 Jun; 105(22):2580-2. PubMed ID: 12045158
    [No Abstract]   [Full Text] [Related]  

  • 18. Indication and techniques of transcatheter closure of patent foramen ovale.
    Schräder R
    J Interv Cardiol; 2003 Dec; 16(6):543-51. PubMed ID: 14632952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case study: closure of a patent foramen ovale without surgery following stroke.
    Duff D
    Axone; 2007; 28(2):42-3. PubMed ID: 17460958
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Butera G; Bini MR; Chessa M; Bedogni F; Onofri M; Carminati M
    Ital Heart J; 2001 Feb; 2(2):115-8. PubMed ID: 11256538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.